| Literature DB >> 34466654 |
Sander F Rodrigo1,2, Henk J Van Exel1, Nicole Van Keulen2, Loes Van Winden2, Saskia L M A Beeres2, Martin J Schalij2.
Abstract
PURPOSE: Cardiac rehabilitation (CR) after hospitalization for acute coronary syndrome (ACS) has shown to reduce mortality, readmissions, and improve quality of life. CR is recommended by international guidelines but previous studies have shown low participation rates. Systematic CR referral might improve CR participation.Entities:
Keywords: ACS, Acute coronary syndrome; CI, Confidence interval; CR, Cardiac rehabilitation; CVA, Cerebrovascular accident; Cardiac rehabilitation; DBC, Diagnosis treatment combination (Diagnose behandel combinatie); EPD, Electronic patient dossier; LV, Left ventricular; NSTEMI, Non ST-elevation myocardial infarction; OR, Odds ratio; Patient participation; Referral; SES, Socio-economic status; STEMI, ST-elevation myocardial infarction; Secondary prevention; TIA, Transient ischemic attack
Year: 2021 PMID: 34466654 PMCID: PMC8382985 DOI: 10.1016/j.ijcha.2021.100858
Source DB: PubMed Journal: Int J Cardiol Heart Vasc ISSN: 2352-9067
Fig. 1Flow of patient selection and number of patients (and percentage of total patient population eligible for CR) referred for CR, participating in CR, and that completed the CR.
Patient characteristics of the total study population, and according to CR referral, CR participation and completion of the CR program.
| Number of patients | 469 | 377 | 92 | 353 | 22 | 318 | 34 | |||
| Male | 341 (73%) | 279 (74%) | 62 (67%) | 0.202 | 259 (74%) | 18 (82%) | 0.382 | 232 (73%) | 26 (77%) | 0.660 |
| Age, years | 63.3 (11.8) | 61.5 (10.9) | 70.8 (12.2) | <0.001 | 61.1 (10.7) | 66.8 (12.7) | 0.017 | 61.4 (10.7) | 58.7 (11.9) | 0.165 |
| Age, categories | ||||||||||
| 56 (12%) | 51 (14%) | 5 (5%) | 0.001 | 49 (14%) | 2 (9%) | 0.209 | 41 (13%) | 8 (24%) | 0.348 | |
| 121 (26%) | 111 (29%) | 10 (11%) | 106 (30%) | 5 (23%) | 96 (30%) | 8 (24%) | ||||
| 141 (30%) | 116 (31%) | 25 (27%) | 110 (31%) | 5 (23%) | 99 (31%) | 11 (32%) | ||||
| 151 (32%) | 99 (26%) | 52 (57%) | 88 (25%) | 10 (46%) | 82 (26%) | 7 (21%) | ||||
| Comorbidities | ||||||||||
| 109 (23%) | 63 (17%) | 46 (50%) | <0.001 | 56 (16%) | 7 (32%) | 0.052 | 49 (15%) | 7 (21%) | 0.433 | |
| 228 (49%) | 172 (46%) | 56 (61%) | 0.009 | 159 (45%) | 13 (59%) | 0.199 | 145 (46%) | 13 (38%) | 0.412 | |
| 158 (34%) | 116 (31%) | 42 (46%) | 0.007 | 111 (31%) | 5 (23%) | 0.391 | 100 (31%) | 9 (27%) | 0.551 | |
| 83 (18%) | 61 (16%) | 22 (24%) | 0.073 | 55 (16%) | 5 (23%) | 0.375 | 49 (15%) | 6 (18%) | 0.733 | |
| 216 (46%) | 179 (48%) | 37 (40%) | 0.203 | 169 (48%) | 9 (41%) | 0.518 | 158 (50%) | 11 (33%) | 0.074 | |
| 40 (9%) | 25 (7%) | 15 (16%) | 0.003 | 24 (7%) | 1 (5%) | 0.681 | 21 (7%) | 3 (9%) | 0.625 | |
| 26 (6%) | 20 (5%) | 6 (7%) | 0.647 | 18 (5%) | 2 (10%) | 0.419 | 18 (6%) | 0 (0%) | 0.154 | |
| Smoking, categories | ||||||||||
| 156 (33%) | 121 (32%) | 35 (38%) | 0.350 | 116 (33%) | 4 (18%) | 0.112 | 103 (32%) | 11 (32%) | 0.07 | |
| 130 (28%) | 103 (27%) | 27 (29%) | 92 (26%) | 10 (46%) | 78 (25%) | 14 (41%) | ||||
| 183 (39%) | 153 (41%) | 30 (33%) | 145 (41%) | 8 (36%) | 137 (43%) | 9 (27%) | ||||
| SES | 0.47 (0.73) | 0.50 (0.72) | 0.35 (0.78) | 0.082 | 0.51 (0.73) | 0.39 (0.59) | 0.455 | 0.52 (0.73) | 0.35 (0.81) | 0.184 |
| SES, categories | ||||||||||
| 106 (22%) | 79 (21%) | 27 (29%) | 0.220 | 72 (20%) | 7 (32%) | 0.442 | 62 (20%) | 10 (29%) | 0.300 | |
| 247 (53%) | 202 (54%) | 45 (49%) | 191 (54%) | 10 (45%) | 172 (54%) | 18 (53%) | ||||
| 116 (25%) | 96 (25% | 20 (22%) | 90 (26%) | 5 (23%) | 84 (26%) | 6 (18%) | ||||
| Diagnosis, categories | ||||||||||
| 76 (16%) | 29 (8%) | 47 (51%) | <0.001 | 28 (8%) | 1 (5%) | 0.769 | 27 (9%) | 1 (3%) | 0.512 | |
| 261 (56%) | 247 (66%) | 14 (15%) | 231 (65%) | 14 (64%) | 208 (65%) | 23 (68%) | ||||
| 132 (28%) | 101 (27%) | 31 (34%) | 94 (27%) | 7 (31%) | 83 (26%) | 10 (29%) | ||||
| LVEF, categories | ||||||||||
| 210 (45%) | 154 (41%) | 56 (61%) | 0.001 | 141 (40%) | 12 (54%) | 0.326 | 123 (39%) | 17 (50%) | 0.381 | |
| 210 (45%) | 184 (49%) | 26 (28%) | 176 (50%) | 7 (32%) | 160 (50%) | 16 (47%) | ||||
| 39 (8%) | 33 (9%) | 6 (7%) | 30 (8%) | 3 (14%) | 29 (9%) | 1 (3%) | ||||
| 10 (2%) | 6 (1%) | 4 (4%) | 6 (2%) | 0 (0%) | 6 (2%) | 0 (0%) | ||||
| Start CR after hospital discharge, days | 32 (32) | 28 (20) | 0.466 | |||||||
| Start CR after hospital discharge | ||||||||||
| < 3 weeks | 134 (42%) | 17 (50%) | 0.194 | |||||||
| 3–6 weeks | 113 (36%) | 14 (41%) | ||||||||
| > 6 weeks | 70 (22%) | 3 (9%) | ||||||||
| Distance to CR center, km | 10.8 (7.5) | 11.0 (7.6) | 9.7 (7.1) | 0.128 | 10.7 (7.5) | 15.0 (9.2) | 0.011 | 10.8 (7.5) | 10.6 (7.5) | 0.873 |
| Distance to CR center | ||||||||||
| 131 (28%) | 100 (27%) | 31 (34%) | 0.082 | 96 (27%) | 4 (18%) | 0.011 | 87 (27%) | 9 (26%) | 0.699 | |
| 139 (30%) | 114 (30%) | 25 (27%) | 109 (31%) | 5 (23%) | 95 (30%) | 13 (38%) | ||||
| 134 (29%) | 104 (28%) | 30 (33%) | 98 (28%) | 4 (18%) | 91 (29%) | 7 (21%) | ||||
| 65 (14%) | 59 (16%) | 6 (6%) | 50 (14%) | 9 (41%) | 45 (14%) | 5 (15%) | ||||
Continuous data are presented as mean (standard deviation); Categorical data are presented as numbers (%).
CR, Cardiac rehabilitation; TIA/CVA, Transient ischemic attack/cerebrovasculair accident; SES, Socio-economic status; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; LVEF, Left ventricular ejection fraction.
Predictors of referral for cardiac rehabilitation.
| Male | 1.3 | (0.84–2.26) | ||
| Age, categories | ||||
| 5.3 | (2.02–14.2) | 4.0 | (1.22–13.4) | |
| 5.8 | (2.81–12.1) | 4.7 | (1.98–11.2) | |
| 2.4 | (1.41–4.21) | 3.5 | (1.69–7.09) | |
| ref | ||||
| Comorbidities | ||||
| 0.2 | (0.12–0.33) | 0.4 | (0.19–0.73) | |
| 0.5 | (0.34–0.86) | 0.7 | (0.41–1.38) | |
| 0.5 | (0.33–0.84) | 1.3 | (0.66–2.38) | |
| 0.6 | (0.35–1.05) | |||
| 1.3 | (0.85–2.15) | |||
| 0.4 | (0.18–7.20) | 0.7 | (0.26–1.74) | |
| 0.8 | (0.31–2.06) | |||
| Smoking, categories | ||||
| ref | ||||
| 1.1 | (0.63–1.95) | |||
| 1.5 | (0.86–2.54) | |||
| SES, categories | ||||
| 0.6 | (0.32–1.17) | |||
| 0.9 | (0.52–1.67) | |||
| ref | ||||
| Diagnosis, categories | ||||
| 0.2 | (0.10–0.35) | 0.2 | (0.08–0.33) | |
| 5.4 | (2.77–10.6) | 2.8 | (1.32–6.02) | |
| ref | ||||
| LVEF, categories | ||||
| ref | ref | |||
| 2.6 | (1.54–4.29) | 2.2 | (1.11–4.52) | |
| 2.0 | (0.80–5.03) | 1.4 | (0.44–4.52) | |
| 0.5 | (0.15–2.01) | 0.8 | (0.16–3.62) | |
| Distance to CR center, categories | ||||
| ref | ref | |||
| 1.4 | (0.78–2.55) | 2.1 | (0.97–4.45) | |
| 1.1 | (0.61–1.90) | 1.2 | (0.58–2.44) | |
| 3.1 | (1.20–7.74) | 4.0 | (1.26–13.0) | |
OR, Odds ratio; CI, Confidence interval; ref, Reference; TIA/CVA, Transient ischemic attack/cerebrovasculair accident; SES, Socio-economic status; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; LVEF, Left ventricular ejection fraction; CR, Cardiac rehabilitation.